Clinical Trial Update: Study to Assess the Prognostic Value of the Antithrombin III in the Acute Pancreatitis (AT-PROPANC)

View source ↗

Summary

A clinical trial evaluating whether antithrombin III levels have prognostic value in patients with acute pancreatitis (AT-PROPANC).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis

Snippet

Sponsor: Francisco Javier García Borobia | Conditions: Acute Pancreatitis | Status: UNKNOWN